Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:1177-1183
Published online before print February 16, 2006, doi: 10.1161/01.ATV.0000214296.94849.1c
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
26/5/1177    most recent
01.ATV.0000214296.94849.1cv1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takeda, N.
Right arrow Articles by Nagai, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takeda, N.
Right arrow Articles by Nagai, R.
Related Collections
Right arrow Cardiovascular Pharmacology
Right arrow Growth factors/cytokines
Right arrow Lipid and lipoprotein metabolism
Right arrow Mechanism of atherosclerosis/growth factors
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:1177.)
© 2006 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Synthetic Retinoid Am80 Reduces Scavenger Receptor Expression and Atherosclerosis in Mice by Inhibiting IL-6

Norifumi Takeda; Ichiro Manabe; Takayuki Shindo; Hiroshi Iwata; Satoshi Iimuro; Hiroyuki Kagechika; Koichi Shudo; Ryozo Nagai

From the Department of Cardiovascular Medicine (N.T., H.I., S.I., R.N.) and Nano Bioengineering Education Program (I.M.), Graduate School of Medicine, University of Tokyo, Tokyo, Japan; and Department of Organ Regeneration, Shinshu University Graduate School of Medicine, Matsumoto, Japan (T.S.), School of Biomedical Science, Tokyo Medical and Dental University, Tokyo (H.K.); Research Foundation Itsuu Laboratory (K.S.), Tokyo, Japan.

Correspondence to Ryozo Nagai, MD, PhD, Department of Cardiovascular Medicine, Graduate School of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo, Tokyo 113-8655, Japan. E-mail nagai-tky{at}umin.ac.jp

Background— Macrophage scavenger receptors facilitate the uptake of modified low-density lipoprotein (LDL), formation of foam cells, and development of atherosclerosis. Given that proinflammatory cytokines, including IL-6, can modulate the macrophage foaming process, the aim of the present study was to determine whether the synthetic retinoic acid receptor-{alpha}/ß-specific agonist Am80, which is also an IL-6 inhibitor, can modulate macrophage lipid accumulation and foam cell formation.

Methods and Results— Am80 suppressed IL-6 production induced by 12-myristate 13-acetate (PMA) or angiotensin II in mouse Raw264 macrophages. It also suppressed expression of the 2 major scavenger receptors (scavenger receptor-A [SR-A] and CD36), in part by inhibiting IL-6, and inhibited macrophage foam cell formation. Systemic administration of Am80 led to reductions in the areas of atherosclerotic lesions and foam cell accumulation in the aortas of apolipoprotein E (apoE)-deficient mice and reduced serum concentrations of IL-6 and IL-1ß without affecting body weights, serum lipid profiles or IL-10 levels.

Conclusions— Am80 suppresses scavenger receptor expression and macrophage foam cell formation in vitro and prevents atherogenesis in apoE-deficient mice in vivo. This suggests Am80 is a novel candidate agent that could be highly useful in the prevention and treatment of atherosclerosis.

Synthetic retinoid Am80 inhibits IL-6 signaling and suppresses scavenger receptor expession in macrophages. Moreover, Am80 prevents macrophage from cell formation in vitro and inhibited atherogenesis in apoE-dificient moce. Am80 is a novel candidate agent that could be highly useful in the prevention and treatment of atherosclerosis.


Key Words: macrophage • IL-6 • CD36 • scavenger receptor-A • retinoid




This article has been cited by other articles:


Home page
Innate ImmunityHome page
H. Loppnow, K. Werdan, and M. Buerke
Invited review: Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms
Innate Immunity, April 1, 2008; 14(2): 63 - 87.
[Abstract] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. Ocaya, A. C. Gidlof, P. S. Olofsson, H. Torma, and A. Sirsjo
CYP26 Inhibitor R115866 Increases Retinoid Signaling in Intimal Smooth Muscle Cells
Arterioscler Thromb Vasc Biol, July 1, 2007; 27(7): 1542 - 1548.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Saito, A. Sugawara, A. Uruno, M. Kudo, H. Kagechika, Y. Sato, Y. Owada, H. Kondo, M. Sato, M. Kurabayashi, et al.
All-trans Retinoic Acid Induces in Vitro Angiogenesis via Retinoic Acid Receptor: Possible Involvement of Paracrine Effects of Endogenous Vascular Endothelial Growth Factor Signaling
Endocrinology, March 1, 2007; 148(3): 1412 - 1423.
[Abstract] [Full Text] [PDF]